Cordis today announced the initiation of a global registry to track real-world outcomes for the Selution SLR drug-eluting ...

The Cordis medical device business that Cardinal Health bought for $1.9 billion is proving to be a millstone for the company. Cordis, a former Johnson & Johnson subsidiary, ran into a raft of ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9470f1/cordis_medical_dev) has announced the addition of the "Cordis Medical ...

After six years, Cardinal Health is dropping its Cordis medical device division, makers of cardiovascular catheters and diagnostic hardware, in a $1 billion deal with private equity firm Hellman ...

Cardinal Health said March 12 it is selling its Cordis medical device business to private equity firm Hellman & Friedman for roughly $1 billion. Cordis makes cardiology and endovascular devices.

Cardinal Health has completed the sale of its Cordis medical device business to private equity firm Hellman & Friedman for about $1 billion, the healthcare services company said Aug 2.

The company highlighted ongoing operational difficulties regarding inventory at its Cordis business, which it bought for $1.9 billion in 2015 from Johnson & Johnson to expand its medical device ...

MENLO PARK, Calif., June 14, 2022 /PRNewswire/ -- Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC ...

Johnson & Johnson plans to seek a buyer for a business that makes medical devices including stents ... The sales process for the business, called Cordis, is at an early stage, the people said.